mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.001 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
Pyrimethamine |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.005 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.005 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.006 |